Acasti Pharma (NASDAQ:ACST) Shares Cross Above Two Hundred Day Moving Average of $2.98

Shares of Acasti Pharma Inc. (NASDAQ:ACSTGet Free Report) passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $2.98 and traded as high as $3.19. Acasti Pharma shares last traded at $3.07, with a volume of 21,847 shares trading hands.

Acasti Pharma Trading Up 0.3 %

The stock’s 50 day moving average price is $2.94 and its 200 day moving average price is $2.98. The firm has a market cap of $28.86 million, a PE ratio of -2.13 and a beta of 1.55.

Acasti Pharma (NASDAQ:ACSTGet Free Report) last issued its earnings results on Friday, June 21st. The biopharmaceutical company reported ($0.18) EPS for the quarter, beating analysts’ consensus estimates of ($0.48) by $0.30. Analysts forecast that Acasti Pharma Inc. will post -1.14 earnings per share for the current year.

Acasti Pharma Company Profile

(Get Free Report)

Acasti Pharma Inc engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company's lead product candidate is the GTX-104, an intravenous infusion to treat subarachnoid hemorrhage. It also develops GTX-102, an oral mucosal spray for the treatment of ataxia-telangiectasia; and GTX-101, a topical bioadhesive film-forming bupivacaine spray for postherpetic neuralgia.

Featured Articles

Receive News & Ratings for Acasti Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acasti Pharma and related companies with MarketBeat.com's FREE daily email newsletter.